In-vivo, cross-sectional and longitudinal study of 18F-APN-1607 investigate positron emission tomography/computed tomography (PET/CT) imaging findings in MAPT mutation carriers
Latest Information Update: 03 Dec 2021
At a glance
- Drugs Florzolotau (Primary)
- Indications Amyotrophic lateral sclerosis; Corticobasal degeneration; Dementia; Parkinsonian disorders; Progressive supranuclear palsy
- Focus Diagnostic use
- 01 Dec 2021 New trial record
- 29 Nov 2021 Results published in the Movement Disorders